Canfield’s VECTRA WB360 was recently installed at the Hopital de la Conception-AP-HM Marseille, making it the first WB360 system to be featured in a French hospital. The whole-body imaging system will be the centerpiece of the hospital’s multi-room system for clinical dermatology, where it includes rooms for body mapping and confocal microscopy. The VECTRA WB360 captures patient images using 46 stereo vision pods with cross-polarized and non-polarized lighting, generating a single 3D image of the entire body. Incorporating Canfield’s AI-driven DermaGraphix® software, the 3D images are used for pigmented lesion and rash surveillance. Using VECTRA’S 3D imaging technology Prof. Jean-Jacques Grob and Jilliana Monnier, MD can examine individual lesions, record data, and monitor patients over time. This latest installation in Marseille is one of fifteen WB360 systems in Europe and is the fifth system so far in 2022.
In the News
Canfield’s Mirror mobile app for iPad was featured recently in the January and February edition of MedEsthetics magazine. Both the Mirror Mobile app and it's new AI-driven module, FaceReality, was included in a list of strategies that can improve patient satisfaction from first encounters to follow-up care. Mirror Mobile app with FaceReality allows physicians to simulate outcomes based on the patient’s desire to improve their first impression, (whether it be healthier, competent, or well-rested) through surgical and non-surgical procedures.
Canfield is proud to announce the VISIA® Skin Analysis System has been voted Favorite Diagnostic Tool in the 2022 Aestheticians' Choice Awards. This is the fourth time VISIA has achieved this award.
Canfield’s VECTRA XT was recently featured on the sixth episode of HBO Max’s 'And Just Like That' where the series' main character Carrie Bradshaw, played by Sarah Jessica Parker, was imaged in an aesthetic consultation. Watch the video below to see her reaction:
Building on its successful expansion into the European dermatology and aesthetics imaging market, Canfield Scientific is announcing the launch of Canfield Scientific s.r.l., created with the acquisition of Medici Medical s.r.l. Medici Medical is responsible for numerous innovations in dermoscopy and has produced best-in-class technology for years, making them the preferred choice of dermatologists in Italy. To celebrate the launch, Alfredo Medici and his team are conducting a special scientific and educational program called Dreamoscopy™, to provide the most advanced learning opportunities in medical imaging, at their brand-new, state of the art facility in Spilamberto (Modena), Italy.
Prof. Pablo Fernandez-Penas of the University of Sydney was recently interviewed on 7News Australia as the University of Queensland and the Australian Cancer Research Foundation announced the official launch of the Australian Centre of Excellence in Melanoma Imaging and Diagnosis (ACEMID). Prof. Fernandez-Penas highlighted the VECTRA WB360 and explained how 15 WB360 systems will be installed as part of this initiative bringing together researchers from the University of Queensland, University of Sydney, and Monash University to study melanoma using the system’s advanced body mapping technology. Prof. Penas is hopeful that up to 15,000 Australians across the states of Queensland, New South Wales, and Victoria will take part in future screenings using the VECTRA WB360, enabling researchers to collect images and develop advanced algorithms to aide melanoma detection.
Canfield’s VECTRA WB360 whole-body imaging system was recently installed at the clinic of Dr. Gerd Kautz and Dr. Ingrid Kautz in Konz, Germany, becoming the first system installed in a German private practice. The 3D imaging system will assist Dr. Gerd Kautz, his wife Dr. Ingrid Kautz, and other staff members as they examine patients for the earliest signs of melanoma using the system’s advanced body mapping technology. The VECTRA WB360 captures patient images using 92 SLR-cameras flashing with polarized and cross-polarized lighting for an enhanced look at skin features. After the images are captured, clinicians can view the entire skin’s surface using Canfield’s AI-driven DermaGraphix software, as they screen for signs of melanoma and monitor changes over time. Starting in early October, staff members at the practice will use the system to examine individual lesions and monitor their patients for potential skin cancer. Their practice is now the fifth VECTRA WB360 installation in Germany, including installations at the University Hospital in Erlangen, University Hospital in Munich, University Hospital in Dresden, and the Technical University of Munich.
University of Queensland’s Prof. H Peter Soyer discusses Canfield’s VECTRA WB360 and its role in expanding Australian melanoma research with 10 News First. Researchers plan to create a database of over 100,000 clinically-accessible VECTRA WB360 patient images, enhancing melanoma screening, early diagnosis, and long-term skin surveillance. The system’s presence at multiple locations in Australia is possible as part of a AUS $10 million grant from the Australian Cancer Research Foundation, as they are using the DermaGraphix advanced body mapping technology to combat the nation’s high rate of melanoma. The VECTRA WB360 captures cross polarized and non-polarized images to create a precise 3D body map of the patient. This 3D body map provides clinicians and researchers the ability to identify changes in suspicious lesions on the surface of the skin over time.
Jack Arbiser, MD, PhD, principal investigator and professor of dermatology at Emory University School of Medicine, has identified a new compound as an effective treatment for rosacea. Canfield’s VISIA Skin Analysis was used in clinical trials to document decreases in redness and track responses to the novel topical treatment, ACU-D1 (Accuitis Inc.).
Canfield’s VECTRA WB360 3D whole body imaging system was recently installed at Vienna General Hospital (AKH) to assist researchers and clinicians as they capture and screen non-polarized and cross-polarized 3D patient images for signs of melanoma and other serious skin conditions. Prof. Kittler is a dermatologist and instructor at the Department of Dermatology at the Medical University of Vienna who specializes in digital dermoscopy. Prof. Kittler has also published several research articles on digital dermoscopy and the dermosopic follow up of melanocytic nevi, as well as contributing to research on patient image standardization. DermaGraphix’s tools will help Prof. Kittler and his colleagues screen patients and conduct advanced research on pigmented lesions more efficiently and effectively.
